Ohio State Navbar


Amy L Pope-Harman, MD

Staff photo

473 W 12th Ave
Columbus, OH 43210

Phone: (614) 293-4925

Email: pope-harman.1@osu.edu


Current OSU Appointments

Associate Professor-Clinical, Pulmonary, Crit Care, & Sleep

Physician, FGP-Pulm, Crit Care, & Sleep


Clinical Interest

Critical Care Medicine;Internal Medicine;Pulmonary Disease;Transplant Med, Lung Transplant, Pulm Med & Transplant, Adv Lung Dz, Palliative Care & Lung Dz

Academic Advising

2010 - present , The Ohio State University.
2011 - present , The Ohio State University.


1992 - present MD: State Medical Board of Ohio
1995 - present Transplant Pulmonologist: United Network for Organ Sharing
- 1990 Board Certification: National Board of Medical Examiners
- 1992 Board Certification: American Board of Internal Medicine
- 1994 Board Certification: American Board of Internal Medicine
- 1995 Board Certification: American Board of Internal Medicine
1995 Temporary Trainee MD: Pennsylvania State Medical Board

Chapters in Books

Medical Nanotechnology and Pulmonary Pathology

Biomedical Nanotechnology for Cancer


Clinical Services

07/01/1995 Pulmonary Outpatient Clinic (Martha Morehouse Plaza)
07/01/1996 Pulmonary Consultation Service (Wexner Medical Center)
07/01/1996 Medical Intensive Care Unit Service (Wexner Medical Canter)
06/01/1998 Medical Director Lung Transplantation (Wexner Medical Center)
10/01/1998 Pulmonary Transplant Outpatient Clinic (Wexner Medical Center)
10/01/2000 Ethics Consultation (Wexner Medical Center)


1985 B.S., The Ohio State University

1989 M.D., The Ohio State University


Editorial Activities

2001 - 2000 NetWellness-Teens Look @Health Website
2005 - 2006 Biomedical Microdevices
2005 - 2007 BioMEMS and Biomedical Nanotechnology
2006 - 2007 Journal of Critical Illness
2008 - present International Journal of Molecular Sciences


present Psi Chi.
0 Alpha Omega Alpha Medical Honor Society. Alpha Omega Alpha.
1981 Ohio Academic Scholarship.
1981 National Merit Scholar.
1989 Outstanding Student in Internal Medicine. Department of Internal Medicine.
1992 Chest Film Interpretation Award. Department of Medicine.
2004 Stellar Performance Award. Lifeline of Ohio.
2005 Best Doctors in America 2005. Best Doctors, Inc..
2005 Top Docs. Columbus Monthly.
2006 Top Docs. Columbus Monthly.
2006 Best Doctors in America 2006. Best Doctors, Inc..
2007 Best Doctors in America 2007. Best Doctors, Inc..
2007 Top Docs. Columbus Monthly.
2008 Top Docs. Columbus Monthly.
2008 Best Doctors in America 2008. Best Doctors, Inc..
2009 Best Doctors in America 2009. Best Doctors, Inc..
2009 Top Docs. Columbus Monthly.
2010 Best Doctors in America 2010. Best Doctors, Inc..
2010 Top Docs. Columbus Monthly.
2011 Top Docs 2011. Columbus Monthly.
2011 Best Doctors in America 2011. Best Doctors, Inc..
2012 Top Docs 2012. Columbus Monthly.
2013 Research Recognition Award. ALA.
2013 John L Robinson Award for Non-Surgical Faculty Teaching of Surgical House Staff. The Ohio State University Department of Surgery.

Journal Articles


Reference Works

May 1994 [begin-bold]Pope-Harman, AL[end-bold], Moore, SA, Wewers, MD, Allen, JN."Inhibition of Cytokine Release and CD-14 Expression by Surfactant Component Phospholipids" . : A94
May 1994 [begin-bold]Pope-Harman, AL[end-bold], Davis, WB, Allen, ED, Christoforidis, AJ, Allen, JN."Radiographic Manifestations of Acute Eosinophilic Pneumonia" . : A431
October 1994 [begin-bold]Pope-Harman, AL[end-bold], Davis, WB, Allen, ED, Allen, JN."Eosinophilic Pneumonia: A Review of Twelve Cases" . : 156S
May 1995 [begin-bold]Pope-Harman, AL[end-bold], Wewers, MD, Allen, JN."Surfactant Phospholipid Effects on Receptors for Endotoxin in Alveolar Macrophages and Blood Monocytes" . : A309
May 2002 Ali, N, Allen, JN, [begin-bold]Pope-Harman, AL[end-bold], Ross, P, Magro, CM."Cytomegalovirus as a Cause of Alveolar Hemorrhage in the Immunocompetent Patient" . : A151
May 2002 Magro, CM, [begin-bold]Pope-Harman, AL[end-bold], Allen, JN, Waldeman, J, Moh, P, Ross, P."Microangiopathic Fibrosing Pneumonitis" . : A152
May 2002 Magro, CM, [begin-bold]Pope-Harman, AL[end-bold], Allen, JN, Ross, P, Morrison, C, Ferri, C, Crowson, AN."Immunofluorescence Testing as an Adjunct in the Diagnosis of Interstitial Lung Disease (ILD)" . : A553
May 2002 Magro, CM, Tandon, R, [begin-bold]Pope-Harman, AL[end-bold], Ross, P,."Post-Transplant Capillaritis Associated with Vascular Co-Factors" . : A393
April 2003 Waldman, WJ, Knight, DA, Ross, P, [begin-bold]Pope-Harman, AL[end-bold], Meister, GT, Magro, CM."Acute Microvascular Injury Associated with Endothelial-Targeted Autoantibodies and Recent Cytomegalovirus Disease" . : 511.6
April 2003 [begin-bold]Pope-Harman, AL[end-bold], Ross, P, Magro, CM."6-Month Outcomes With and Without Antithymocyte Globulin Induction" . : A615
April 2003 [begin-bold]Pope-Harman, AL[end-bold], Magro, CM, Ross, P, Kelsey, M."Activation of the Classic Complement Cascade Sequence in Patient Undergoing Lung Transplantation With and Without Antithymocyte Globulin Induction: A Comparative Study" . : S120
April 2003 [begin-bold]Pope-Harman, AL[end-bold], Syrinivasan, M, Magro, CM, Ross, P."Assessment of the Phenotypic Profile and T Cell Clonality in Biopsies of Lung Allograft Rejection" . : S137
April 2003 [begin-bold]Pope-Harman, AL[end-bold], Ross, P, Magro, CM, Kelsey, M."C4d as a Diagnostic Adjunct in Lung Allograft Biopsies" . : S103
April 2003 [begin-bold]Pope-Harman, AL[end-bold], Magro, CM, Ross, P."Activation of Complement and Markers of Endothelial Cell Injury in Patients Undergoing Lung Transplantation With and Without Antithymocyte Globulin Induction" . : A248
June 2005 Knight, DA, Magro, CM, Adams, PW, Ross, P, [begin-bold]Pope-Harman, AL[end-bold]."Characterization of Endothelial-Reactive, Non-MHC Antibodies in Lung allograft Dysfunction" .
May 2006 Nunley,DR, Cahill, L, Bauldoff,GS, Ross, P, [begin-bold]Pope-Harman, AL[end-bold]."The Lung Allocation Score and Survival in COPD Lung Transplant Candidates" .
May 2008 Nunley, DR, Bauldoff, GS, [begin-bold]Pope-Harman, AL[end-bold], Ali, N."Outcomes of Solid Organ Transplant Recipients in a Medical ICU" .
May 2009 Nunley, DR, Bauldoff, GS, Carter, S, Moffatt-Bruce, SD, [begin-bold]Pope-Harman, AL[end-bold]."Mild and Moderate Hypoxia-Induced Pulmonary Hypertension Does Not Adversely Impact Survival Following Single Lung Transplantation" .
May 2010 Nunley, DR, Bauldoff, GS, Holloman, CH, Baran, C, [begin-bold]Pope-Harman, AL[end-bold], Moffatt-Bruce, SD, , Wood, KL."Cigarette Smoking Following Lung Transplantation: Short-Term Effects on the Allograft" . : A4313
May 2011 Nunley, DR, Baran, C, Holloman, CH, Bauldoff, GS, Carter, S, [begin-bold]Pope-Harman, AL[end-bold], Wood, K."Changes in Pulmonary Function and Interleukin-8 Expression in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome: Effects of Azithromycin Therapy" .
May 2012 Nunley, DR, Bauldoff, GS, Holloman, CH, Carter, S, [begin-bold]Pope-Harman, AL[end-bold]."Severity of Bronchiolitis Obliterans Syndrome and Functional Performance In Lung Transplant Recipients" .
April 2012 O’Keefe, K, Kilic, A, Pope-Harman, A, Hayes, D, Kirkby, S, Higgins, R, Whitson, B."Pulmonary artery pressure changes differentially affect survival in pulmonary hypertension and COPD transplant recipients: An analysis of the UNOS STAR Registry" .
September 2012 Kirby, S, Hassan, A, Satoskar, A, Brodsky, S, Nadasdy, T, Hitchcock, C, Ross, P, [begin-bold]Pope-Harman, AL[end-bold], Nunley, D, Shilo, K."Morphological Spectrum of Pulmonary Manifestations in Heart Transplant Recipients" .
April 2013 Whitson, BA Lehman, A, Wehr A, Hayes Jr, D, Kirkby, S, Pope-Harman, A, Kilic, A, Higgins, RSD."To Induce or Not to Induce: A 21st Century Evaluation of Lung Transplant" .


January 2000 Pope-Harman AL."NetWellness--Teens Look at Health" NetWellness
January 2009 Pope-Harman, AL."NetWellness" NetWellness


Hypersensitivity Pneumonitis: Case Report

Surfactant Phospholipid Effects on Cytokine Release and CD 14 Receptors

Broncho-Biliary Fistula: Case Report

Legionella Pneumonia

Eosinophilic Lung Diseases

Acute Eosinophilic Pneumonia

Pulmonary Transplantation

Eosinophilic Lung Diseases

Lung Transplantation

Lung Transplantation

Ethical and Legal Aspects of DNR

Lung Transplantion

Ethics in Transplantation

Lung Transplantion

Smoking Cessation

Lung Transplantation Update

Issues in Lung Transplantation

Implementation of DNR-CC and DNR-CC-Arrest in the Intensive Care Unit

C4d and Lung Transplantation

End-Stage Lung Diseases

Humoral Immunity in Lung Transplantation: New insights into post-graft pathology

Lung Transplantation

CPC: A 46 yo man with respiratory failure and lymphocytosis

Ethical Aspects of Advances in Medical Technology

Implementation of Nanotechnology in Medicine

Ethics of Healthcare Technology

End of Life Myths

Hospital Ethics Committees

Ethics Cases

Medical Literacy

Structure and Function of Hospital Ethics Committee

Medical Management of the Post-Lung Transplant Patient

Lung Transplantation

Ethics Cases

Ethics 101

Lung Transplant Cases

Myths, Truth, and Beauty on End of Life Issues

End of Life Issues

Ethical and Societal Considerations in Nanotechnology

Ethics of Medical Nanotechnology

Ethics in Transplantation

Management of Patients with ARDS

The Role of Ethics Committees in the Modern Medical Center

Medical Ethics Cases

End Stage Lung Diseases

Ethics Considerations and Cases

Understanding Mechanisms in the Development of Bronchiolitis Obliterans Syndrome

Lung Transplant in LAM

End Stage Lung Diseases

End Stage Lung Diseases

Pulmonary hypertension


Allergic bronchopulmonary aspergillosis.


Professional Activities

present Consultant regarding Ethics of Medical Nanotechnology. Consumer Reports.
1983 - 1985 Suicide Prevention.
2001 - 2002 Central Ohio Trauma System Ethics Task Force. Central Ohio Trauma System.
2001 - 2002 Self-organized interest group.
2005 Special Consultant to Ethics Committee. Fairfield Medical Center.
2003 - 2006 Multi-disciplinary Collaborative Research Discussion Group.
2002 - 2007 Research Discussion and Collaboration.